Efficacy and safety of oral and early-switch therapy for community-acquired pneumonia: a randomized controlled trial
- 1 October 2001
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Medicine
- Vol. 111 (5) , 367-374
- https://doi.org/10.1016/s0002-9343(01)00868-3
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Canadian Guidelines for the Initial Management of Community-Acquired Pneumonia: An Evidence-Based Update by the Canadian Infectious Diseases Society and the Canadian Thoracic SocietyClinical Infectious Diseases, 2000
- Variation in length of hospital stay in patients with community-acquired pneumonia: are shorter stays associated with worse medical outcomes?The American Journal of Medicine, 1999
- The Cost of Treating Patients with Community-Acquired PneumoniaSeminars in Respiratory and Critical Care Medicine, 1999
- Community-acquired pneumonia in adultsCurrent Opinion in Infectious Diseases, 1998
- Practical Considerations and Guidelines for the Management of Community-Acquired PneumoniaDrugs, 1998
- Community-acquired pneumonia: the annual cost to the National Health Service in the UKEuropean Respiratory Journal, 1997
- The antibiotic treatment of community-acquired, atypical, and nosocomial pneumoniasMedical Clinics of North America, 1995
- Antibiotic treatment of community-acquired pneumonia in clinical practice: a European perspectiveJournal of Antimicrobial Chemotherapy, 1995
- Medical Section pf the American Lung Association: Guidelines for the Initial Management of Adults with Community-acquired Pneumonia: Diagnosis, Assessment of Severity, and Initial Antimicrobial TherapyAmerican Review of Respiratory Disease, 1993
- Intervention to Discontinue Parenteral Antimicrobial Therapy in Patients Hospitalized with Pulmonary Infections: Effect on Shortening Patient StayInfection Control & Hospital Epidemiology, 1992